Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Celldex Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CLDX.
You can purchase shares of Celldex Therapeutics (NASDAQ:CLDX) through any online brokerage.
Other companies in Celldex Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
Celldex Therapeutics has a consensus price target of $61.00.
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $20.975 last updated May 2, 2025 at 2:35 PM EDT.
There are no upcoming dividends for Celldex Therapeutics.
Celldex Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Celldex Therapeutics.
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.